143 related articles for article (PubMed ID: 18274836)
1. Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors.
Takabatake D; Taira N; Aogi K; Ohsumi S; Takashima S; Inoue T; Nishimura R
Breast Cancer; 2008; 15(2):181-4. PubMed ID: 18274836
[TBL] [Abstract][Full Text] [Related]
2. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
[TBL] [Abstract][Full Text] [Related]
3. Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
Krammer J; Wasser K; Schnitzer A; Henzler T; Schoenberg SO; Kaiser CG
Eur J Radiol; 2013 Dec; 82(12):2194-8. PubMed ID: 23993142
[TBL] [Abstract][Full Text] [Related]
4. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Zhao TT; Li JG; Li YM
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
[TBL] [Abstract][Full Text] [Related]
5. Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
Ohsumi S; Inoue T; Kiyoto S; Hara F; Takahashi M; Takabatake D; Takashima S; Aogi K; Takashima S
Breast Cancer Res Treat; 2011 Nov; 130(1):267-72. PubMed ID: 21590272
[TBL] [Abstract][Full Text] [Related]
6. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.
Monzawa S; Adachi S; Suzuki K; Hirokaga K; Takao S; Sakuma T; Hanioka K
Ann Nucl Med; 2009 Dec; 23(10):855-61. PubMed ID: 19876704
[TBL] [Abstract][Full Text] [Related]
8. Occult breast carcinoma presenting as an axillary mass.
Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer.
Chae BJ; Bae JS; Kang BJ; Kim SH; Jung SS; Song BJ
Jpn J Clin Oncol; 2009 May; 39(5):284-9. PubMed ID: 19318373
[TBL] [Abstract][Full Text] [Related]
10. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
11. Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy.
Koolen BB; Valdés Olmos RA; Vogel WV; Vrancken Peeters MJ; Rodenhuis S; Rutgers EJ; Elkhuizen PH
Breast Cancer Res Treat; 2013 Sep; 141(2):249-54. PubMed ID: 24002735
[TBL] [Abstract][Full Text] [Related]
12. Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
Groheux D; Moretti JL; Baillet G; Espie M; Giacchetti S; Hindie E; Hennequin C; Vilcoq JR; Cuvier C; Toubert ME; Filmont JE; Sarandi F; Misset JL
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):695-704. PubMed ID: 18436392
[TBL] [Abstract][Full Text] [Related]
13. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
[TBL] [Abstract][Full Text] [Related]
14. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071
[TBL] [Abstract][Full Text] [Related]
15. Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
Asakura H; Takashima H; Mitani M; Haba R; Seo R; Yokoe K; Toyama Y; Ohkawa M
Int J Clin Oncol; 2005 Aug; 10(4):285-8. PubMed ID: 16136377
[TBL] [Abstract][Full Text] [Related]
16. Herpes Zoster Mimicking Breast Cancer With Axillary Lymph Node Metastasis on PET/CT.
Choi EK; Oh JK; Chung YA
Clin Nucl Med; 2015 Jul; 40(7):572-3. PubMed ID: 26018707
[TBL] [Abstract][Full Text] [Related]
17. Occult breast primary malignancy presenting as isolated axillary lymph node metastasis - early detection of primary site by 18F-FDG PET/CT.
Soundararajan R; Naswa N; Karunanithi S; Walia R; Kumar R; Bal C
Nucl Med Rev Cent East Eur; 2016; 19(B):5-7. PubMed ID: 27813620
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
[TBL] [Abstract][Full Text] [Related]
19. [Papillary thyroid carcinoma synchronous with breast cancer: an incidental finding in an (18)F-FDG PET-CT study carried out in a search for occult breast cancer].
Banzo J; Ubieto MA; González C; Razola P; Tardín L; Andrés A; Santapau A; Parra A; Rambalde EF; Prats E
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):213-5. PubMed ID: 23067689
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
